FibroGen Inc (NASDAQ:FGEN)
| 13.27 Delayed Data As of Jul 23 |  -0.37 / -2.71%Today’s Change | 13.11 Today|||52-Week Range 57.21 | -64.22% Year-to-Date |
Latest FGEN News | Press Releases
| Here's Why FibroGen Stock Is Plunging Today Jul 16 / MotleyFool.com - Paid Partner Content | FibroGen (FGEN) Roxadustat Fails to Win FDA Advisory Panel Vote Jul 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 13.64 |
| Today’s open | 13.65 |
| Day’s range | 13.11 - 13.65 |
| Volume | 67,699 |
| Average volume (3 months) | 1,625,527 |
| Market cap | $1.3B |
Data as of 3:59pm ET, 07/23/2021
Growth & Valuation
| Earnings growth (last year) | -137.10% |
| Earnings growth (this year) | +31.85% |
| Earnings growth (next 5 years) | -59.04% |
| Revenue growth (last year) | -31.28% |
| P/E ratio | NM |
| Price/Sales | 18.90 |
| Price/Book | 3.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Oxford BioMedica PLC | 0.00 | 0.00% |
| AVXLAnavex Life Sciences... | -1.32 | -5.91% |
| AMRNAmarin Corporation P... | -0.10 | -2.43% |
| DBVTDBV Technologies SA | +0.39 | +7.75% |
Data as of 4:11pm ET, 07/23/2021
Financials
| Next reporting date | August 9, 2021 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $176.3M |
| Annual profit (last year) | -$189.3M |
| Net profit margin | -107.36% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
